Oracle’s, Rout

Oracle’s 64% Rout: A Technical Bounce Masks Questions That $638 Billion in Backlog Can’t Answer

Published on 07/27/2026 at 18:07 | Redaktion boerse-global.de

Oracle shares snap six-week slide with oversold bounce, yet analyst targets of €219 contrast with heavy OpenAI dependency and insider selling risks.

Oracle Stock Bounces 4.76% After 64% Plunge, But Rally Is Mechanical Not Fundamental
Oracle’s 64% Rout: A Technical Bounce Masks Questions That $638 Billion in Backlog Can’t Answer Illustration mit AI erstellt übermittelt durch boerse-global.de

Oracle shares jumped 4.76% on Monday to €106.02, snapping a six-week slide that erased more than half the company’s market value. The move felt like relief, but beneath the surface, the rally looks more like a mechanical snap-back than a fundamental turning point.

The stock had become deeply oversold. The 14-day relative strength index sat at 33.7 before the rebound — firmly in oversold territory — and the shares were trading 27.85% below their 50-day moving average and 33.08% below the 200-day average. By Friday’s close at €101.20, Oracle was just 0.14% above its 52-week low of €101.06, a level reached only the prior week. From the September 2025 high of €280.70, the stock has now lost nearly 64%.

Those conditions are precisely the kind that trigger sharp, disproportionate rallies when sentiment stabilizes even slightly. Short-sellers covering positions and bargain hunters stepping in can produce outsized daily gains. The Monday move fits that pattern: mechanical, not fundamental.

Wall Street’s Price Targets Tell a Conflicting Story

Despite the rout, analysts have largely held their ground. The average price target stands at €219.11 — more than double the current share price. Mizuho reiterated a $320 target as recently as July 2026, arguing the market is treating Oracle like a company with a spending problem while ignoring the enormous backlog of contracted revenue yet to be recognized.

Should investors sell immediately? Or is it worth buying Oracle?

That backlog is staggering. At the end of fiscal 2026, Oracle reported remaining performance obligations of $638 billion — signed contracts that must still be fulfilled. The centerpiece is “Project Stargate,” the five-year, $300 billion infrastructure partnership with OpenAI, officially confirmed in late 2025. It positions Oracle as a critical energy and computing partner for the next generation of artificial intelligence.

The gap between the average analyst target of €219.11 and the current price of roughly €106 reflects genuine optionality on the AI business. But it also reflects a market that hasn’t decided whether Oracle’s massive bet will be rewarded or punished.

The Single-Customer Risk That Overshadows Everything

The most legitimate reason for caution isn’t the scale of Oracle’s capital spending — it’s the concentration. According to S&P estimates, roughly half of Oracle’s $638 billion in remaining performance obligations comes from a single customer: OpenAI.

That dependency cuts both ways. If OpenAI continues to grow and remains well-funded, Oracle’s infrastructure wager could generate exceptional returns for years. If AI demand slows or OpenAI pulls back, Oracle is left holding long-term data-center leases that would be difficult to re-market at attractive terms. That is the core of the bear case, and an oversold bounce does nothing to resolve it.

Jeffrey Henley, Oracle’s vice chairman, sold 400,000 shares in June at significantly higher prices, adding to the downward pressure and reinforcing the narrative that even insiders see reason to take money off the table.

Financing Remains the Central Debate

Even the most optimistic voices acknowledge that the near-term debate isn’t about fundamentals — it’s about financing. Evercore analysts, who maintain a buy rating, wrote that debt levels, leverage, and the pace of new equity issuance will remain the central investor debate, even if demand signals are strong.

Oracle is pursuing an unprecedented hardware strategy to service its backlog. In October 2025, the company announced plans to operate the first public AI supercluster with 50,000 AMD Instinct MI450 chips, diversifying its chip supply beyond existing partnerships with Nvidia and Ampere. The rollout begins in the current quarter.

The bigger execution risk, however, isn’t chips — it’s power. Zettascale data centers require energy volumes that conventional grids can barely supply. Larry Ellison has confirmed that Oracle is planning a gigawatt-scale data center powered by three small modular nuclear reactors. The technology is new, regulatory timelines are uncertain, and the build-out will take years. Still, Oracle has secured construction permits for all three reactors, putting it further ahead on the energy problem than most competitors.

Oracle at a turning point? This analysis reveals what investors need to know now.

In June 2026, Oracle added another piece to the puzzle: OCI customers can now use their Universal Credits directly for OpenAI models and Codex. That integration lowers the barrier for enterprise adoption and creates the kind of customer stickiness that tends to be overlooked during selloffs.

The Next Catalyst

With a market capitalization of €291.16 billion, Oracle is being valued as if its current investment cycle is a burden rather than an investment in a $638 billion backlog. The stock trades just above its 52-week low, with an RSI that dipped to 27.6 — well below the oversold threshold of 30 — and sits roughly 31% below its 50-day average of €148.04. Such wide deviations are rare and typically signal either a bottom or a fundamental re-rating.

The next real test comes with fiscal first-quarter 2027 results, expected in early September 2026. That report will show whether the Stargate backlog and AI infrastructure spending are finally being priced back into the stock — or whether the market’s skepticism will persist.

For now, the Monday bounce offers a reminder that deeply oversold conditions can produce powerful short-term moves. But the structural questions that drove Oracle from €280.70 to just over €100 remain unanswered: financing needs, rating-agency sensitivity, and a backlog dominated by a single customer whose own funding is uncertain. Anyone buying into this strength should keep the distinction between a technical recovery and a resolved investment case firmly in mind.

Ad

Oracle Stock: New Analysis - 27 July

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLE’S | boerse | 69886417 |